Research Misconduct in Low- and Middle-Income Countries

Research Misconduct in Low- and Middle-Income Countries

As part of a cluster of articles critically reflecting on the theme of "no health without research," Richard Smith and colleagues lay out what is currently known about research misconduct in low- and middle-income countries, summarizing some high profile cases and making suggestions on ways forward.

Research Priorities for Medical Toxicology in Low and Middle Income Countries

In the editorial by Dr. Reza Afshari “What is the best research for low income countries” (1), some important issues have been raised, highly relevant to developing countries. In most developing countries including India, emergency medicine is not well established and clinical toxicology is even further a low priority in view of both research and clinical management. The number of poison contro...

Mental health research publications from low- and middle-income countries

Anaemia in low-income and middle-income countries.

Anaemia affects a quarter of the global population, including 293 million (47%) children younger than 5 years and 468 million (30%) non-pregnant women. In addition to anaemia's adverse health consequences, the economic effect of anaemia on human capital results in the loss of billions of dollars annually. In this paper, we review the epidemiology, clinical assessment, pathophysiology, and conse...

Paediatric cancer in low-income and middle-income countries.

Patterns of cancer incidence across the world have undergone substantial changes as a result of industrialisation and economic development. However, the economies of most countries remain at an early or intermediate stage of development-these stages are characterised by poverty, too few health-care providers, weak health systems, and poor access to education, modern technology, and health care ...